Pharmacy Drugs
Recent Posts
- Experimental MS Drug Withdrawn From Trial
- Over 50 Pharmacists Trained Up For NPA’s Seasonal Flu Vaccination Service
- The Minister For Health&Children Commences The Outstanding Sections Of The Pharmacy Act 2007 Dealing With Complaints, Inquires And Discipline, Ireland
- Foresight Biotherapeutics Announces Initiation Of Viral Conjunctivitis Clinical Trial
- Study Of Pulmonary Hypertension Treatment In Sickle Cell Patients Halted By NHLBI
Random Posts
- BioAlliance Pharma Presents Additional US Pivotal Phase III Results On Loramyc™ (Miconazole Lauriad(R)) At The 47Th Annual Meeting Of The IDSA
- Over 50 Pharmacists Trained Up For NPA's Seasonal Flu Vaccination Service
- New Breast MRI Technology Enables Enhanced Breast Cancer Detection
- Pharmacy Sector Steps Up Joint Work, England
- Medtronic Completes Enrollment In International Post-Market Study Of Resolute Drug-Eluting Stent
- FDA Warns of Bacteria in Nasal Spray
- Conference To Offer Important Insights And Information On Sponsor Relationships With Clinical Oversight Group, Oct. 14-15, 2009, Loews, Philadelphia
- Australian Medical Association Urges Careful Use Of Anti-viral Medicines
- MHRA Unlicensed Medicines Consultation - Pharmacy Bodies Respond
- FDA Finds Oral Insulin Spray Safe for IND Use
Data Indicates Rising Adoption Of Technology In Canadian Clinical Trials
Posted by: admin in Pharmacy Drugs on March 25th, 2010
A research team led by Dr. Khaled El Emam, the Canada Research Chair in Electronic Health Information at the CHEO Research Institute, evaluated the use of technology in Canadian clinical trials, and found that a significant proportion (41%) have moved away from collecting and managing trial data using only paper records.
In his study titled “The Use of Electronic Data Capture Tools in Clinical Trials: Web-survey of 259 Canadian Trials” published in the Journal of Medical Internet Research, Dr. El Emam and his team found that during the 2006 and 2007 calendar years, there were approximately 950 clinical trials registered with sites in Canada. About half of these were funded by the pharmaceutical industry. Industry trials tend to be 3 to 4 times larger, on average, than academic trials. Less than 10% of Canadian trials target a pediatric population, which also tend to be significantly smaller than those targeting adult populations. Industry funded trials were more likely to be using electronic data capture (EDC) tools. There was no difference between pediatric and adult trials in terms of the use of EDC, but pediatric trials were using more sophisticated EDC systems.
Electronic data capture tools allow researchers to complete a trial in less time and with fewer errors than if they were using the old paper method to capture and process data manually before entering it into a computer.
“The adoption of technology to collect and manage data in clinical trials is increasing, but mostly for industry funded trials. Should academic trials continue to move in that direction, they are expected to gain efficiency and quality benefits.” explained Dr. El Emam.
Source: Isabelle Mailloux
Children’s Hospital of Eastern Ontario Research Institute
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.